Cite
HARVARD Citation
Malek, A. et al. (n.d.). 1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation. Open forum infectious diseases. p. S809. [Online].